The Total Artificial Heart in End-Stage Congenital Heart Disease
The development of durable ventricular assist devices (VADs) has improved mortality rates and quality of life in patients with end stage heart failure. While the use of VADs has increased dramatically in recent years, there is limited experience with VAD implantation in patients with complex congeni...
Main Authors: | Chet R. Villa, David L. S. Morales |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-05-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphys.2017.00131/full |
Similar Items
-
Expanding the Performance Envelope of the Total Artificial Heart: Physiological Characterization, Development of a Heart Failure Model, And Evaluation Tool for Mechanical Circulatory Support Devices
by: Crosby, Jessica Renee
Published: (2014) -
SPECIAL ASPECTS OF IMPLANTATION OF A HEART PUMP SUPPORT SYSTEM AVK-N AS A «BRIDGE» TO HEART TRANSPLANTATION
by: T. A. Khalilulin, et al.
Published: (2018-04-01) -
Status on Heart Transplantation in China
by: Xing-Jian Hu, et al.
Published: (2015-01-01) -
10-YEAR HEART TRANSPLANTATION EXPERIENCE IN NOVOSIBIRSK
by: A. M. Chernyavskiy, et al.
Published: (2018-04-01) -
Mechanical circulation support of the treatment for children with end-stage chronic heart failure
by: S. V. Gautier, et al.
Published: (2017-09-01)